The offering price is $22 for each share of 6,818,182 shares of stock. Additionally, the company granted underwriters a 30-day option to purchase up to an additional 1,022,727 shares of common stock, according to a Dec. 7 Syndax news release provided to Becker’s.
The offering is expected to formally close Dec. 9.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
